348 related articles for article (PubMed ID: 17084759)
1. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.
Weidle PJ; Wamai N; Solberg P; Liechty C; Sendagala S; Were W; Mermin J; Buchacz K; Behumbiize P; Ransom RL; Bunnell R
Lancet; 2006 Nov; 368(9547):1587-94. PubMed ID: 17084759
[TBL] [Abstract][Full Text] [Related]
2. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
Ferradini L; Jeannin A; Pinoges L; Izopet J; Odhiambo D; Mankhambo L; Karungi G; Szumilin E; Balandine S; Fedida G; Carrieri MP; Spire B; Ford N; Tassie JM; Guerin PJ; Brasher C
Lancet; 2006 Apr; 367(9519):1335-42. PubMed ID: 16631912
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kazé S; Molinari N; Bourgeois A; Mpoudi-Ngolé E; Spire B; Koulla-Shiro S; Delaporte E;
Lancet Infect Dis; 2011 Nov; 11(11):825-33. PubMed ID: 21831714
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda.
Bajunirwe F; Tisch DJ; King CH; Arts EJ; Debanne SM; Sethi AK
AIDS Care; 2009 Mar; 21(3):271-9. PubMed ID: 19280404
[TBL] [Abstract][Full Text] [Related]
5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
6. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
[TBL] [Abstract][Full Text] [Related]
7. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers.
Coetzee B; Kagee A; Vermeulen N
AIDS Care; 2011 Feb; 23(2):146-51. PubMed ID: 21259126
[TBL] [Abstract][Full Text] [Related]
8. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
[TBL] [Abstract][Full Text] [Related]
9. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK;
AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.
Weidle PJ; Malamba S; Mwebaze R; Sozi C; Rukundo G; Downing R; Hanson D; Ochola D; Mugyenyi P; Mermin J; Samb B; Lackritz E
Lancet; 2002 Jul; 360(9326):34-40. PubMed ID: 12114039
[TBL] [Abstract][Full Text] [Related]
12. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
[TBL] [Abstract][Full Text] [Related]
13. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
[TBL] [Abstract][Full Text] [Related]
14. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
15. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
[TBL] [Abstract][Full Text] [Related]
16. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
17. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
[TBL] [Abstract][Full Text] [Related]
18. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trial.
Woodd SL; Grosskurth H; Levin J; Amuron B; Namara G; Birunghi J; Coutinho A; Jaffar S
AIDS; 2014 Feb; 28(4):569-76. PubMed ID: 24468997
[TBL] [Abstract][Full Text] [Related]
19. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
[TBL] [Abstract][Full Text] [Related]
20. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.
Mermin J; Ekwaru JP; Were W; Degerman R; Bunnell R; Kaharuza F; Downing R; Coutinho A; Solberg P; Alexander LN; Tappero J; Campbell J; Moore DM
BMJ; 2011 Nov; 343():d6792. PubMed ID: 22074711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
